These success, together with a prior report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the principle of focusing on ACKR3 as a novel approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders. The site is protected. https://traudli405dtj0.thechapblog.com/profile